Annual Net Income
-$59.69 M
-$1.30 M-2.22%
December 31, 2023
Summary
- As of February 7, 2025, MIST annual net profit is -$59.69 million, with the most recent change of -$1.30 million (-2.22%) on December 31, 2023.
- During the last 3 years, MIST annual net income has fallen by -$9.72 million (-19.45%).
- MIST annual net income is now -638.13% below its all-time high of -$8.09 million, reached on December 31, 2017.
Performance
MIST Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$9.44 M
-$76.00 K-0.81%
September 30, 2024
Summary
- As of February 7, 2025, MIST quarterly net profit is -$9.44 million, with the most recent change of -$76.00 thousand (-0.81%) on September 30, 2024.
- Over the past year, MIST quarterly net income has increased by +$5.64 million (+37.41%).
- MIST quarterly net income is now -1325.84% below its all-time high of $770.00 thousand, reached on June 30, 2021.
Performance
MIST Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$42.77 M
+$5.64 M+11.65%
September 30, 2024
Summary
- As of February 7, 2025, MIST TTM net profit is -$42.77 million, with the most recent change of +$5.64 million (+11.65%) on September 30, 2024.
- Over the past year, MIST TTM net income has increased by +$16.48 million (+27.82%).
- MIST TTM net income is now -922.89% below its all-time high of -$4.18 million, reached on March 31, 2018.
Performance
MIST TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
MIST Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.2% | +37.4% | +27.8% |
| 3 y3 years | -19.4% | +36.9% | +27.9% |
| 5 y5 years | -157.4% | +36.9% | +27.9% |
MIST Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -39.3% | at low | -0.8% | +44.1% | at high | +31.1% |
| 5 y | 5-year | -39.3% | at low | -1325.8% | +48.4% | -32.0% | +31.1% |
| alltime | all time | -638.1% | at low | -1325.8% | +48.4% | -922.9% | +31.1% |
Milestone Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.44 M(+0.8%) | -$42.77 M(-11.7%) |
| Jun 2024 | - | -$9.36 M(-9.6%) | -$48.41 M(-12.1%) |
| Mar 2024 | - | -$10.35 M(-23.9%) | -$55.09 M(-7.7%) |
| Dec 2023 | -$59.69 M(+2.2%) | -$13.61 M(-9.7%) | -$59.69 M(+0.7%) |
| Sep 2023 | - | -$15.08 M(-6.0%) | -$59.25 M(+0.9%) |
| Jun 2023 | - | -$16.04 M(+7.3%) | -$58.73 M(-1.0%) |
| Mar 2023 | - | -$14.95 M(+13.5%) | -$59.33 M(+1.6%) |
| Dec 2022 | -$58.39 M(+36.3%) | -$13.18 M(-9.5%) | -$58.39 M(-6.0%) |
| Sep 2022 | - | -$14.56 M(-12.6%) | -$62.09 M(+0.5%) |
| Jun 2022 | - | -$16.65 M(+18.9%) | -$61.76 M(+39.3%) |
| Mar 2022 | - | -$14.01 M(-17.0%) | -$44.35 M(+3.5%) |
| Dec 2021 | -$42.85 M | -$16.88 M(+18.7%) | -$42.85 M(+23.7%) |
| Sep 2021 | - | -$14.22 M(-1947.4%) | -$34.63 M(+6.9%) |
| Jun 2021 | - | $770.00 K(-106.2%) | -$32.39 M(-29.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$12.51 M(+44.4%) | -$46.14 M(-7.7%) |
| Dec 2020 | -$49.97 M(-9.5%) | -$8.67 M(-27.7%) | -$49.97 M(-16.1%) |
| Sep 2020 | - | -$11.98 M(-7.7%) | -$59.59 M(-1.4%) |
| Jun 2020 | - | -$12.98 M(-20.6%) | -$60.44 M(-1.1%) |
| Mar 2020 | - | -$16.34 M(-10.6%) | -$61.12 M(+10.7%) |
| Dec 2019 | -$55.23 M(+138.2%) | -$18.29 M(+42.5%) | -$55.23 M(+18.4%) |
| Sep 2019 | - | -$12.83 M(-6.1%) | -$46.66 M(+18.0%) |
| Jun 2019 | - | -$13.66 M(+30.7%) | -$39.53 M(+34.2%) |
| Mar 2019 | - | -$10.45 M(+7.6%) | -$29.46 M(+27.0%) |
| Dec 2018 | -$23.18 M(+186.7%) | -$9.72 M(+70.5%) | -$23.19 M(+72.1%) |
| Sep 2018 | - | -$5.70 M(+58.8%) | -$13.47 M(+73.4%) |
| Jun 2018 | - | -$3.59 M(-14.2%) | -$7.77 M(+85.8%) |
| Mar 2018 | - | -$4.18 M | -$4.18 M |
| Dec 2017 | -$8.09 M | - | - |
FAQ
- What is Milestone Pharmaceuticals annual net profit?
- What is the all time high annual net income for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals annual net income year-on-year change?
- What is Milestone Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals quarterly net income year-on-year change?
- What is Milestone Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals TTM net income year-on-year change?
What is Milestone Pharmaceuticals annual net profit?
The current annual net income of MIST is -$59.69 M
What is the all time high annual net income for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high annual net profit is -$8.09 M
What is Milestone Pharmaceuticals annual net income year-on-year change?
Over the past year, MIST annual net profit has changed by -$1.30 M (-2.22%)
What is Milestone Pharmaceuticals quarterly net profit?
The current quarterly net income of MIST is -$9.44 M
What is the all time high quarterly net income for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high quarterly net profit is $770.00 K
What is Milestone Pharmaceuticals quarterly net income year-on-year change?
Over the past year, MIST quarterly net profit has changed by +$5.64 M (+37.41%)
What is Milestone Pharmaceuticals TTM net profit?
The current TTM net income of MIST is -$42.77 M
What is the all time high TTM net income for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high TTM net profit is -$4.18 M
What is Milestone Pharmaceuticals TTM net income year-on-year change?
Over the past year, MIST TTM net profit has changed by +$16.48 M (+27.82%)